• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Ex-Lutonix R&D veep Barry pleads guilty to trade secret theft

Ex-Lutonix R&D veep Barry pleads guilty to trade secret theft

May 10, 2017 By Brad Perriello

Gavel, handcuffsThe former vice president of R&D for drug-coated balloon maker Lutonix, Christopher Barry, yesterday pleaded guilty to a single count of trade secret theft in federal court in Minneapolis.

Barry, who left Lutonix in 2015 to become CEO of Urotronic, admitted to downloading 6 files in April 2015 containing trade secrets about the development of the drug coating for the Lutonix balloon and transferred the files to his work computer at Urotronic. C.R. Bard (NYSE:BCR) paid $325 million to acquire Lutonix in December 2011.

Lutonix incurred $534,000 in investigative and legal fees in dealing with the case, which Barry will pay back, according to court documents. He faces a prison sentence of 2 to 2.5 years, according to the documents; a date for a sentencing hearing has not been set.

Urotronic told the Minneapolis Star Tribune that the design for its DCB, intended to treat strictures of the urethra, was complete before Barry joined the company.

“Urotronic had no knowledge of or involvement with Mr. Barry’s actions. When Urotronic learned of his actions, it demanded his resignation,” the company said in a statement to the newspaper. “Urotronic’s product was developed before Mr. Barry was hired and Mr. Barry had no involvement in the development of the Urotronic technology.”

Defense attorney Jim Volling of Faegre Baker Daniels told the paper that Barry plans to ask for less prison time than recommended in the sentencing guidelines.

“Mr. Barry recognizes that he made a poor judgment and did something that he deeply regrets,” Volling told the Star Tribune. “I’ve been very impressed by Mr. Barry and his integrity, and his desire to move on with his life and accept responsibility for what happened.”

Filed Under: Drug-Device Combinations, Legal News Tagged With: C.R. Bard, Drug-Eluting Balloons, Lutonix Inc., urotronic

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy